Concepedia

Author

Chim C. Lang

Ninewells HospitalORCID

Also Known As

Aroon D Hingorani, Benjamin Szwejkowski, C C L Lang, C C Lang, C LANG, C Lang, C. C. LANG, C. C. Lang, C. Lang, C.C Lang

713

Publications

26.9K

Citations

82

H-Index

170

Concepts

All Affiliations

Ninewells HospitalUniversity of DundeeUniversity of LeicesterGlenfield HospitalUniversity of Groningen
CC

About

Chim C. Lang is an author at Ninewells Hospital specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

42

69

9.4K

2

Health Sciences

14

16

1.2K

3

Engineering

2

2

111

4

Nursing

2

2

34

5

Language Studies

1

1

121

Chim C. Lang

×

235

Publications

21.9K

Citations

74

H-Index

YearCitations

Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study

Salim Yusuf, Steven Hawken, Stephanie Ôunpuu,

The Lancet

2005

2.9K

QT dispersion and sudden unexpected death in chronic heart failure

Craig Barr, A. A O Naas, Monica R. Freeman,

The Lancet

1994

770

Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status

Amy Cameron, Vicky L. Morrison, Daniel L. Levin,

Circulation Research

2016

686

Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure

Donna Mancini, Stuart D. Katz, Chim C. Lang,

Circulation

2003

540

Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors

Iziah E Sama, Alice Ravera, Bernadet T. Santema,

European Heart Journal

2020

487

Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study

Wouter Ouwerkerk, A.A. Voors, S. D. Anker,

European Heart Journal

2017

391

Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial

Awsan Noman, D. S. C. Ang, Simon Ogston,

The Lancet

2010

346

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Paul R. Kalra, John G.F. Cleland, Mark C. Petrie,

The Lancet

2022

344

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

John G.F. Cleland, John R. Teerlink, Roxy Senior,

The Lancet

2011

329

Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease

Craig Barr, Chim C. Lang, Jacqueline Hanson,

The American Journal of Cardiology

1995

316

Page 1